Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 506 entries
View as:

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00004157 Org: User:
Start: 08/31/00 End: 04/30/02 Due: 04/30/03

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05075759 Org: User:
Start: 06/06/22 End: 09/20/26 Due: 09/20/27

Cancer Communication Within Hispanic Social Networks

Phase: N/A Priority: Normal
NCT ID: NCT04444232 Org: User:
Start: 09/09/14 End: 03/09/15 Due: 03/09/16

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Phase: N/A Priority: Normal
NCT ID: NCT01300572 Org: User:
Start: 01/31/12 End: 11/22/19 Due: 11/22/20

Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00547235 Org: User:
Start: 09/30/07 End: - Due: -

Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT05067595 Org: User:
Start: 01/24/25 End: 12/31/26 Due: 12/31/27

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00346359 Org: User:
Start: 03/31/06 End: 11/30/07 Due: 11/30/08

Reducing Insulin, Growth Hormones, and Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03785808 Org: User:
Start: 12/21/18 End: 08/05/19 Due: 08/05/20

Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02662296 Org: User:
Start: 03/31/16 End: - Due: -

Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02521961 Org: User:
Start: 02/03/16 End: 07/01/17 Due: 07/01/18

Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00860171 Org: User:
Start: 02/28/09 End: 03/21/20 Due: 03/21/21

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00032279 Org: User:
Start: 03/31/02 End: - Due: -

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking

Phase: N/A Priority: Normal
NCT ID: NCT06145763 Org: User:
Start: 12/01/25 End: 11/30/28 Due: 11/30/29

Promoting Activity and Changes in Eating (PACE) to Reduce Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00119782 Org: User:
Start: 09/30/04 End: 11/30/09 Due: 11/30/10

Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT00006234 Org: User:
Start: 11/30/01 End: 03/31/06 Due: 03/31/07

Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study

Phase: N/A Priority: Normal
NCT ID: NCT04922697 Org: User:
Start: 09/15/21 End: 03/05/22 Due: 03/05/23

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Phase: N/A Priority: Normal
NCT ID: NCT05250037 Org: User:
Start: 03/30/22 End: 06/30/28 Due: 06/30/29

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01056614 Org: User:
Start: 09/30/04 End: 04/30/16 Due: 04/30/17

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05930496 Org: User:
Start: 07/26/25 End: 10/31/25 Due: 10/31/26

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT06484595 Org: User:
Start: 09/23/24 End: 06/01/26 Due: 06/01/27

Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT06752694 Org: User:
Start: 08/01/25 End: 06/01/27 Due: 06/01/28

Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02226497 Org: User:
Start: 01/09/15 End: 08/30/18 Due: 08/30/19

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT01729845 Org: User:
Start: 12/20/12 End: 04/03/17 Due: 04/03/18

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01961115 Org: User:
Start: 09/13/13 End: 05/18/17 Due: 05/18/18

Move and Moderate in Balance

Phase: N/A Priority: Normal
NCT ID: NCT00715130 Org: User:
Start: 09/30/05 End: 08/31/10 Due: 08/31/11